Marburg hemorrhagic fever

0
Marburg hemorrhagic fever

Marburg hemorrhagic fever (MHF) is an acute viral disease belonging to the group of viral hemorrhagic fevers. This pathology is caused by the Marburg virus from the Filoviridae family, which is transmitted to humans from infected animals, mainly from bats. Symptoms of the disease include high fever, muscle pain, headache, vomiting, diarrhea and, in the later stages, severe hemorrhagic manifestations, which can lead to severe complications and death. The infection is characterized by a high mortality rate, reaching 90%, which makes it one of the most dangerous viral infections.

History of the disease and interesting historical facts

Marburg haemorrhagic fever was first reported in 1967 in Marburg, Germany, and in Yugoslavia, when an outbreak linked to work in virus laboratories affected researchers working with monkeys imported from Africa. The initial outbreak resulted in 31 cases and 7 deaths. However, the infection has had predecessors in similar viruses, such as Ebola, raising interest in the study of transmission routes and host defence mechanisms. In tropical African countries such as the Republic of Congo, outbreaks occur periodically in poor medical infrastructure, particularly among locals involved in agriculture or wildlife.

Epidemiology

According to the World Health Organization (WHO), cases of Marburg haemorrhagic fever have been reported in several countries, including Uganda, Congo, Kenya and Ghana. Overall statistics show that fewer than 500 cases have been reported since the virus was discovered, which is an isolated phenomenon compared to other haemorrhagic fevers. However, the high fatality rate and potential threat of epidemics raise serious concerns in the medical community. Outbreaks of the disease can be triggered by consumption of monkey meat or contact with infected animals, which indicates the need for zoonotic control.

Genetic predisposition to this disease

There is currently insufficient data on hereditary predisposition to Marburg haemorrhagic fever, as the disease is caused by a virus rather than mutations in human genes. However, individual differences in immune response to the virus may be influenced by genetic factors, including variations in genes responsible for the antiviral response. Understanding these mechanisms may help develop more effective methods of protection and treatment of viral infections.

Risk factors for the development of this disease

The main risk factors for developing Marburg hemorrhagic fever include:

  • Working in laboratories with potentially dangerous pathogens.
  • Employment in agriculture, especially in areas where bats are common.
  • Contact with infected animals, including when preparing and eating wild game meat.
  • Living and working in epidemic conditions, which increases the likelihood of contact with infected people.

These factors significantly increase the risk of infection and the development of clinical manifestations of the disease.

Diagnosis of this disease

Diagnosis of Marburg hemorrhagic fever involves a comprehensive approach based on clinical manifestations and laboratory test results.

Main symptoms:

  • High temperature (up to 40 degrees Celsius)
  • Nausea and vomiting
  • Muscle pain
  • Diarrhea
  • Hemorrhagic manifestations (bleeding from the gums, nose, intestines)

Laboratory tests:

  • Polymerase chain reaction (PCR) for virus detection.
  • Enzyme-linked immunosorbent assay (ELISA) for antibodies to the virus.
  • Complete blood count for thrombocytopenia and leukopenia.

Radiological examinations:

  • Ultrasound examination to assess the condition of organs and tissues.
  • CT scan to detect complications such as hematomas.

Differential diagnosis:

  • Viral hepatitis
  • Dengue fever
  • Ebola fever
  • Typhus

Conducting a comprehensive diagnosis is critical for early detection of the disease and the use of appropriate therapy.

Treatment

Treatment of Marburg hemorrhagic fever is primarily symptomatic and supportive, as there are currently no specific antiviral agents. Pharmacological treatment may include:

  • Dehydration: Electrolyte solutions are administered while fluid levels are maintained.
  • Control of temperature indicators with the help of antipyretic drugs.
  • Immunotherapy, which is currently in development and clinical trials.

Surgical treatment may be required in case of hemorrhagic complications or other critical conditions such as organ ruptures.

Additionally, methods of supporting the function of organs and systems are used. Patients require careful monitoring for developing complications.

List of medications used to treat this disease

There are currently no specific antiviral drugs for the treatment of Marburg hemorrhagic fever, but the following are being used in research:

  • Ribavirin
  • Monoclonal antibodies, experimental

These drugs were in the clinical trials stage and their use requires further evaluation of safety and effectiveness.

Disease monitoring

Monitoring the condition of patients with Marburg hemorrhagic fever is important for timely detection of complications and correction of treatment. Monitoring includes:

  • Regular measurement of body temperature and monitoring of hemodynamic parameters.
  • Laboratory monitoring of electrolyte balance and platelet levels.
  • Assessment of the functional state of the liver and kidneys.

The prognosis for patients depends on the timeliness of treatment, but high mortality remains a serious problem. Complications can include chronic pain, organ dysfunction, and mental health problems.

Age-related features of the disease

Marburg hemorrhagic fever can affect people of all ages, but the severity can vary. Children and older adults often have more severe disease because their immune response is weaker. Young adults may have milder symptoms, but the risk of complications remains high.

Questions and Answers

  • What is Marburg hemorrhagic fever? It is an acute viral disease caused by the Marburg virus, characterized by high mortality and hemorrhagic symptoms.
  • How is Marburg virus transmitted? The virus is transmitted to humans from infected animals, mainly bats, and between people through contact with bodily fluids.
  • What are the main symptoms of the disease? The main symptoms include high fever, muscle pain, headache, vomiting, diarrhea and hemorrhagic manifestations.
  • How is the disease diagnosed? Diagnosis is based on the clinical picture, laboratory tests (PCR, ELISA) and differential diagnosis with other fevers.
  • How is Marburg hemorrhagic fever treated? Treatment is symptomatic and supportive, aimed at controlling symptoms and preventing complications.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.